

Author: Ziegelbauer Karl Light David R
Publisher: Palgrave Macmillan Ltd
ISSN: 1478-565X
Source: Journal of Commercial Biotechnology, Vol.14, Iss.1, 2008-01, pp. : 65-72
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Anti-phytochelatin monoclonal antibody
By Satofuka H.
Biotechnology Letters, Vol. 22, Iss. 17, 2000-09 ,pp. :


Overcoming obstacles to monoclonal antibody product development and approval
By Stein K.E.
Trends in Biotechnology, Vol. 15, Iss. 3, 1997-03 ,pp. :



